These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6838521)

  • 1. Paradoxical effect of leupeptin in vivo on cathepsin B activity.
    Sutherland JH; Greenbaum LM
    Biochem Biophys Res Commun; 1983 Jan; 110(1):332-8. PubMed ID: 6838521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid proteolytic activities in mouse liver and muscle tissues after treatment with protease inhibitor leupeptin.
    Salminen A; Kihlström M; Vihko V
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 79(1):93-5. PubMed ID: 6149885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles.
    Libby P; Goldberg AL
    Science; 1978 Feb; 199(4328):534-6. PubMed ID: 622552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the protease inhibitor leupeptin on proteolytic activities and regeneration of mouse skeletal muscles after exercise injuries.
    Salminen A
    Am J Pathol; 1984 Oct; 117(1):64-70. PubMed ID: 6385726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence demonstration of cathepsin B activity in skeletal, cardiac, and vascular smooth muscle.
    Stauber WT; Ong SH
    J Histochem Cytochem; 1981 Jul; 29(7):866-9. PubMed ID: 7264276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic modification of rat liver fructose-1,6-bisphosphate aldolase by administration of leupeptin in vivo.
    Kominami E; Hashida S; Katunuma N
    Biochim Biophys Acta; 1981 Jun; 659(2):378-89. PubMed ID: 7020765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leupeptin as a tool for the detection of the sites of catabolism of rat high-density lipoprotein apolipoproteins A-I and E.
    van 't Hooft FM; Dallinga-Thie GM; van Tol A
    Biochim Biophys Acta; 1985 Mar; 834(1):75-84. PubMed ID: 2579677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of serum albumin by rat liver and kidney lysosomes.
    Ohshita T; Hiroi Y
    J Nutr Sci Vitaminol (Tokyo); 1998 Oct; 44(5):641-53. PubMed ID: 9919484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of rat liver fructose biphosphate aldolase by lysosomal proteinases.
    Katunuma N; Kominami E; Hashida S; Wakamatsu N
    Adv Enzyme Regul; 1982; 20():337-50. PubMed ID: 7051771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequestration of cytoplasmic enzymes in an autophagic vacuole-lysosomal system induced by injection of leupeptin.
    Kominami E; Hashida S; Khairallah EA; Katunuma N
    J Biol Chem; 1983 May; 258(10):6093-100. PubMed ID: 6133857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of leupeptin on the intracellular maturation of lysosomal cathepsin L in primary cultures of rat hepatocytes.
    Nishimura Y; Kato K; Furuno K; Himeno M
    Biol Pharm Bull; 1995 Jul; 18(7):945-50. PubMed ID: 7581248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of beta-galactosidase in beta-galactosidase-alpha-neuraminidase deficiency: effects of leupeptin and sucrose.
    Kato T; Okada S; Yutaka T; Yabuuchi H
    Biochem Int; 1983 Feb; 6(2):267-73. PubMed ID: 6433925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of leupeptin on the autophagic vacuolar system of rat hepatocytes. Correlation between ultrastructure and degradation of membrane and cytosolic proteins.
    Henell F; Glaumann H
    Lab Invest; 1984 Jul; 51(1):46-56. PubMed ID: 6330453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selective role of cathepsins B and D in the lysosomal degradation of endogenous and exogenous proteins.
    Kominami E; Ueno T; Muno D; Katunuma N
    FEBS Lett; 1991 Aug; 287(1-2):189-92. PubMed ID: 1715285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat mammary gland in culture secretes a stable high molecular weight form of cathepsin L.
    Recklies AD; Mort JS
    Biochem Biophys Res Commun; 1985 Aug; 131(1):402-7. PubMed ID: 4038303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The slow, tight-binding inhibition of cathepsin B by leupeptin. A hysteretic effect.
    Baici A; Gyger-Marazzi M
    Eur J Biochem; 1982 Dec; 129(1):33-41. PubMed ID: 7160384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appearance of autolysosomes in rat liver after leupeptin treatment.
    Furuno K; Ishikawa T; Kato K
    J Biochem; 1982 May; 91(5):1485-94. PubMed ID: 6178729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of myofibrillar proteins by cathepsins B and D.
    Bird JW; Schwartz WN; Spanier AM
    Acta Biol Med Ger; 1977; 36(11-12):1587-604. PubMed ID: 616706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased activities of cathepsin B and other lysosomal hydrolases in fibroblasts and bone tissue cultured in the presence of cysteine proteinases inhibitors.
    Montenez JP; Delaissé JM; Tulkens PM; Kishore BK
    Life Sci; 1994; 55(15):1199-208. PubMed ID: 7934617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cathepsin B. Application of the substrate N-benzyloxycarbonyl-L-arginyl-L-arginine 2-naphthylamide to a study of the inhibition by leupeptin.
    Knight CG
    Biochem J; 1980 Sep; 189(3):447-53. PubMed ID: 7213339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.